TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.

TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.

Show other versions (1)

In cancer patients, plasma often contains mutant DNA released by cancer cells. We have assessed the significance of plasma DNA mutations for subsequent cancer development in healthy subjects in a large longitudinal prospective study. The European Prospective Investigation into Cancer and Nutrition s...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Gormally, E, Vineis, P, Matullo, G, Veglia, F, Caboux, E, Le Roux, E, Peluso, M, Garte, S, Guarrera, S, Munnia, A, Airoldi, L, Autrup, H, Malaveille, C, Dunning, A, Overvad, K, Tjønneland, A, Lund, E, Clavel-Chapelon, F, Boeing, H, Trichopoulou, A, Palli, D, Krogh, V, Tumino, R, Panico, S, Bueno-de-Mesquita, H
פורמט: Journal article
שפה:English
יצא לאור: 2006

פריטים דומים

פריטים דומים